Compare AdaptHealth Corp (AHCO) vs McDonald's Corp (MCD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs McDonald's Corp — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while McDonald's Corp trades at $278.2 (market cap $200.51B). The key difference: McDonald's Corp is far larger — about 145.3× AdaptHealth Corp's market cap, and McDonald's Corp pays a 2.64% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | MCD | |
|---|---|---|
Market Cap | $1.38B | $200.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $341.06 |
52-Week Low | $8.68 | $264.54 |
Enterprise Value | $3.33B | $254.22B |
Volume | — | 2,230,036 |
Dividend Yield | — | 2.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
McDonald's (MCD) trades at $279.5, down 0.4% on the day, as the stock navigates a challenging consumer environment. The company reported solid Q1 2026 earnings that beat expectations, with revenue reaching $26.89B in 2025 and a robust net income margin of 31.62%. Technical analysis shows a bullish overall signal despite mixed moving averages, with key support at $275 and resistance at $282. Recent news highlights the company's new 'McDonald's>NEXT' growth strategy focused on automation and menu innovation to win back customers.
The outlook for MCD is cautiously optimistic, supported by strong analyst consensus (58% Buy rating) and a $325.50 price target implying significant upside. Investment opportunities include the company's durable franchise model, consistent dividend payments, and strategic initiatives to improve operations. Key risks involve persistent inflationary pressures on franchisee margins, intense competition in the value segment, and execution challenges of the new growth strategy amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →
